花旗:新高教(2001.HK)“內生+外延”雙輪驅動 上調目標價至8.3港元 評級“買入”
格隆匯4月30日丨花旗發研報指,在領先的內生增長以及穩健式自建和併購“雙輪驅動”戰略驅動下,新高教集團(2001.HK)業績表現亮眼,符合該行預期,重申 “買入”評級,並大幅提升目標價,由7.9港元上調至8.3港元。花旗認為,市場對民促法落地情緒轉向正面,加上集團的甘肅學校和華中學校在2021年3月一次性順利完成轉設,且在近期完成了甘肅學校並表,併成功收購鄭州學校,後續兩所學校將為集團新增效益。花旗表示,新高教資金儲備充裕,截至2021年2月底,在手現金約16億元人民幣,並擁有9億元人民幣未動用銀行授信額度。而新設立的20億元人民幣信託計劃,也將能夠助力集團外延發展,未來可期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.